Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N5LJ
|
||||
Former ID |
DNC000782
|
||||
Drug Name |
Igmesine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Phase 2 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H30ClN
|
||||
Canonical SMILES |
CCC(CC=CC1=CC=CC=C1)(C2=CC=CC=C2)N(C)CC3CC3.Cl
|
||||
InChI |
1S/C23H29N.ClH/c1-3-23(22-14-8-5-9-15-22,24(2)19-21-16-17-21)18-10-13-20-11-6-4-7-12-20;/h4-15,21H,3,16-19H2,1-2H3;1H/b13-10+;
|
||||
InChIKey |
SCHQQPAJNUHKSV-RSGUCCNWSA-N
|
||||
CAS Number |
CAS 140850-73-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sigma(1)-type opioid receptor | Target Info | Agonist | [2], [3], [4] | |
WikiPathways | miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001429) | ||||
REF 2 | Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels. Eur J Neurosci. 2002 May;15(9):1523-34. | ||||
REF 3 | Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs. 2004;18(5):269-84. | ||||
REF 4 | Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J Pharmacol Exp Ther. 2006 Jun;317(3):1307-19. Epub 2006 Mar 21. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.